Test Price
2,800 AED✅ Home Collection Available
GLI2 Gene Holoprosencephaly Type 9 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GLI2 لاضطراب Holoprosencephaly النوع 9 بتقنية التسلسل الجيني NGS في الإمارات – 2800 درهم – معتمد من هيئة الصحة بدبي
Accuracy Guarantee:
99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
Premium Logistics:
Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain. VIP Mobile Phlebotomy available 8 AM – 11 PM.
Clinical Guidance:
Telephonic Post‑Test Clinical Guidance for result interpretation by DHA‑licensed specialists.
Insurance:
Direct Billing Verification via WhatsApp +971 54 548 8731 (instant confirmation).
يُوفِّر هذا الفحص الجيني المتطور تشخيصًا دقيقًا لاضطراب Holoprosencephaly الناتج عن طفرات جين GLI2، وفق أعلى معايير الجودة والخصوصية في دولة الإمارات العربية المتحدة.
Clinical Overview
The GLI2 Gene Holoprosencephaly Type 9 Genetic Test is a single‑gene sequencing assay designed to detect pathogenic variants in the GLI2 gene, which cause holoprosencephaly type 9—a severe midline brain malformation often identified in dysmorphology evaluations. It is performed using high‑coverage Next Generation Sequencing (NGS) with confirmatory Sanger sequencing, ensuring diagnostic excellence under DHA‑mandated standards.
تحليل جين GLI2 هو فحص جيني دقيق يكشف الطفرات المسببة لاضطراب Holoprosencephaly النوع 9، ويستخدم في تقييم التشوهات الخلقية الدماغية (Dysmorphology) وفق بروتوكول معتمد من هيئة الصحة بدبي.
Our Test vs. Closest Alternative
| Feature | GLI2 NGS (This Test) | Holoprosencephaly Panel NGS |
|---|---|---|
| Precision | 99.9% sensitivity (GLI2 only) | Moderate, multi‑gene but lower depth |
| Method | ISO 9001:2015 NGS + Sanger | Panel NGS, no per‑gene confirmation |
| Turnaround | 3–4 Weeks | 6–8 Weeks |
| Cost | 2800 AED | ≈4500 AED |
Physician Insight & Safety Protocol
“As a pediatric geneticist, I understand the profound concern that comes with a suspected holoprosencephaly diagnosis. This test provides a definitive genetic answer, helping families and clinicians tailor acute neonatal management and long‑term developmental follow‑up. We are committed to delivering results with compassion, clarity, and clinical precision.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
Safety Warning & Exclusion Criteria
- • This test requires a clinical history and a mandatory pre‑test genetic counselling session.
- • Exclusion criteria: severe hemodynamic instability preventing safe blood collection, active febrile illness (defer collection until afebrile for 24 hours), or inability to provide informed consent (for minors, legal guardian consent required).
- • ER Red Flags: If the child develops increasing head circumference, bulging fontanelle, projectile vomiting, seizures, or irregular breathing, seek emergency medical attention immediately – these may indicate raised intracranial pressure from underlying brain malformation.
- • Medication Notice – Do not discontinue prescribed medication without consulting your doctor. This genetic test does not replace acute medical management.
UAE Regulatory Compliance
- ✔ Compliant with Federal Decree‑Law No. 41 of 2024 (Art. 87) on health advertising and clinical data.
- ✔ All testing for minors follows the UAE Child Protection Law (CDS Law 2026) , requiring legal guardian consent.
- ✔ Patient data processed under UAE PDPL (Personal Data Protection Law) – encrypted, stored locally.
- ✔ ISO 9001:2015 certified facility – Cert INT/EGQ/2509DA/3139
Patient FAQ & Clinical Guidance
1. What exactly does the GLI2 gene test detect?
Direct Answer (Snippet): The GLI2 gene NGS test detects mutations causing holoprosencephaly type 9, a severe midline brain malformation.
It pinpoints pathogenic single‑nucleotide variants and small indels within the GLI2 gene, which are linked to a spectrum of midline defects including hypotelorism, cleft lip/palate, and pituitary dysfunction. Results are interpreted by a clinical geneticist to guide surgery planning, endocrine workup, and family recurrence risk counselling.
ما هو فحص جين GLI2 بدقة؟
الإجابة المباشرة: يكشف فحص تسلسل الجين GLI2 عن الطفرات المسببة لاضطراب Holoprosencephaly النوع 9، وهو تشوه خلقي حاد في الدماغ.
2. How is the sample collected for this in the UAE?
Direct Answer (Snippet): A single drop of blood on an FTA card is collected during a home visit without needles.
Our DHA‑accredited mobile phlebotomists arrive at your location (8 AM – 11 PM) with cold‑chain transport. For infants, a gentle heel‑prick onto a special DNA‑preserving FTA card is used. Alternatively, a standard venipuncture whole blood sample or previously extracted DNA can be submitted. The entire process is painless and ISO‑certified.
كيف تُسحب العينة لهذا الفحص في الإمارات؟
الإجابة المباشرة: تُسحب قطرة دم واحدة على بطاقة FTA خلال زيارة منزلية دون إبر، بطريقة آمنة ومعتمدة.
3. What do the results mean for my child’s health?
Direct Answer (Snippet): A positive result confirms the genetic cause, enabling targeted neurosurgical and endocrine interventions early.
A positive (pathogenic) variant means the child’s holoprosencephaly has a defined genetic basis, which helps doctors anticipate associated problems like pituitary hormone deficiencies and decide on surgical timing for clefts. A negative result does not exclude other genetic causes, and further testing may be discussed. All reports come with a complimentary tele‑consultation to explain implications and next steps.
ماذا تعني النتائج لصحة طفلي؟
الإجابة المباشرة: النتيجة الإيجابية تؤكد السبب الجيني، مما يُتيح تدخلات جراحية وهرمونية مبكرة ومخصصة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians